JACK LUNDERMAN: Open Payments
NPI 1871694679 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 68 payments from 16 companies in 2025. Trend: 2023 $1,375 · 2024 $1,638 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $195 |
| Otsuka America Pharmaceutical, Inc. | 10 | $157 |
| Vanda Pharmaceuticals Inc. | 8 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $106 |
| Lundbeck LLC | 5 | $99 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| Alkermes, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Tris Pharma Inc | 3 | $50 |
Products named: REXULTI, HETLIOZ, AUSTEDO XR, TRINTELLIX, UZEDY, Auvelity, INGREZZA, ARISTADA.
Industry payments across OH — which companies pay providers there.
